The overarching question imparting urgency to this exploration is: Can U.S.-Russian contention in cyberspace cause the two nuclear superpowers to stumble into war? In considering this question we were constantly reminded of recent comments by a prominent U.S. arms control expert: At least as dangerous as the risk of an actual cyberattack, he observed, is cyber operations’ “blurring of the line between peace and war.” Or, as Nye wrote, “in the cyber realm, the difference between a weapon and a non-weapon may come down to a single line of code, or simply the intent of a computer program’s user.”
Dr. Lee D. Fiebert, PharmD, MBA, BCPS, CPHQ, is the Senior Assistant Vice President of Business Operations and Senior Corporate Health Project Advisor at NYC Health + Hospitals. He received his pharmacy degree from St. John’s University and his MBA with a major in health services management from Hofstra University. He completed a PGY-1 pharmacy residency at Northwell’s Long Island Jewish Medical Center and a PGY-2 health-system pharmacy administration residency at the Lebanon VA Medical Center. At NYC Health + Hospitals, he serves as the Senior Assistant Vice President of Business Operations and a Senior Corporate Health Project Advisor. In this role, he is responsible for the development and integration of initiatives, services, and programs from the Office of Business Operations into the Health System. During the 2020 COVID-19 pandemic, he served as NYC H+H’s technical and operational lead for the vaccine roll-out across the enterprise. Dr. Fiebert is a board-certified pharmacotherapy specialist and a certified professional in healthcare quality.
Dr. Andrew B. Wallach, MD, FACP, is the Ambulatory Care Chief at NYC Health + Hospitals/Bellevue, Ambulatory Care Chief Medical Officer at NYC Health + Hospitals, and Chief Medical Officer for NYC Test & Trace Corps. He received his undergraduate degree in History (cum laude) from Duke University and his medical degree from the University of North Carolina at Chapel Hill, where he also completed his residency training in Internal Medicine. At NYC Health + Hospitals/Bellevue, he serves as the Ambulatory Care Chief. In this role, he leads the Ambulatory Care Service Line and works with the Clinic Chiefs to improve access, quality and patient satisfaction throughout Ambulatory Care. At NYC H+H, he serves as the Ambulatory Care Chief Medical Officer. In this role, he is responsible for leading the overall clinical vision for Ambulatory Care throughout the Enterprise in order to provide high quality medical care for patients as well as to align staff to meet the changing environment in healthcare: the shift to population health management, value-based purchasing, and risk pool management. Throughout the 2020 COVID-19 pandemic, he has led the testing initiatives and COVID-19 vaccination efforts at NYC Health + Hospitals and was named Chief Medical Officer for the NYC Test & Trace Corps. A clinician-educator, he is currently an Associate Professor of Medicine in the Department of Medicine, Division of General Internal Medicine and Clinical Innovation (DGIMCI) at the NYU Grossman School of Medicine and serves as the DGIMCI Associate Director for Clinical Innovations and Clinical Affairs.